Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease defined using a number of wellestablished molecular subsets. Application of non-negative matrix factorization (NMF) to whole exome sequence data has previously been used to identify six distinct molecular clusters in DLBCL with potential clinical relevance. |

TÀI LIỆU LIÊN QUAN

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters

Genomic subtyping of liver cancers with prognostic application

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

Identification of a pyroptosis-related prognostic signature in breast cancer

Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma